Philip Morris International (PMI) did not deliberately mislead investors about clinical trials for its Iqos heated tobacco system or about the product’s prospects in Japan, a US federal court has ruled ...
Are you already a subscriber? login here
Need help?
Contact a sales representative right now and don’t wait
Erik Galavis
+34 654 320 547
Email Erik
Pablo Sharrock
+34 722 642 678
Email Pablo
